Correlation Between Oncopeptides and Sedana Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oncopeptides and Sedana Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncopeptides and Sedana Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncopeptides AB and Sedana Medical AB, you can compare the effects of market volatilities on Oncopeptides and Sedana Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncopeptides with a short position of Sedana Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncopeptides and Sedana Medical.

Diversification Opportunities for Oncopeptides and Sedana Medical

0.75
  Correlation Coefficient

Poor diversification

The 3 months correlation between Oncopeptides and Sedana is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Oncopeptides AB and Sedana Medical AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sedana Medical AB and Oncopeptides is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncopeptides AB are associated (or correlated) with Sedana Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sedana Medical AB has no effect on the direction of Oncopeptides i.e., Oncopeptides and Sedana Medical go up and down completely randomly.

Pair Corralation between Oncopeptides and Sedana Medical

Assuming the 90 days trading horizon Oncopeptides AB is expected to under-perform the Sedana Medical. In addition to that, Oncopeptides is 1.19 times more volatile than Sedana Medical AB. It trades about -0.05 of its total potential returns per unit of risk. Sedana Medical AB is currently generating about 0.0 per unit of volatility. If you would invest  2,084  in Sedana Medical AB on August 30, 2024 and sell it today you would lose (862.00) from holding Sedana Medical AB or give up 41.36% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Oncopeptides AB  vs.  Sedana Medical AB

 Performance 
       Timeline  
Oncopeptides AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncopeptides AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Sedana Medical AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sedana Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Oncopeptides and Sedana Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oncopeptides and Sedana Medical

The main advantage of trading using opposite Oncopeptides and Sedana Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncopeptides position performs unexpectedly, Sedana Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sedana Medical will offset losses from the drop in Sedana Medical's long position.
The idea behind Oncopeptides AB and Sedana Medical AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated